Antioxidant inhibition of porphyrin-induced cellular phototoxicity.
Porphyrins such as protoporphyrin IX (PP IX) and uroporphyrin I (UP I) can be phototoxic to human cells. To study the protective ability of antioxidants (beta-carotene, lycopene, ascorbic acid and alpha-tocopherol), against such porphyrin phototoxicity, membrane destruction experiments (Jurkat cells) and human cell cultures (fibroblasts) were performed. Both beta-carotene and lycopene and also the combination of beta-carotene, ascorbic acid and alpha-tocopherol offered cell protection against PP IX phototoxicity. Investigations of both cell membrane protection and of cell growth showed differences in terms of the protection afforded by the anti-oxidants. Thus, for PP IX, carotenoids alone, and in combination with ascorbic acid and alpha-tocopherol, showed higher protection factors in general than UP I. However, for membrane protection there was significant protection against UP I by the combination of beta-carotene, ascorbic acid and alpha-tocopherol but not by any of these anti-oxidants alone. The membrane protection against PP IX by beta-carotene, and especially lycopene, is significant presumably because of the high lipophilicity of all these molecules. However, the hydrophilic UP I will cause phototoxicity mainly via H(2)O(2), radical or singlet oxygen production in the aqueous phase, and these reactive species may be generated some distance from the cell membrane. This may lead to the little or no protection observed for UP I by the individual antioxidants. Nevertheless, a combination of beta-carotene, ascorbic acid and alpha-tocopherol offers membrane protection against the phototoxicity of both porphyrins. This is believed to occur as a result of synergistic processes. Our results suggest that the treatment of porphyria cutanea tarda and erythropoietic protoporphyria may be improved by the use of a combination of the antioxidants studied.
Böhm
F
F
Department of Dermatology (Charité), Humboldt University, Schumannstrasse 20/21, 10117 Berlin, Germany. fritz.boehm@charite.de
Edge
R
R
Foley
S
S
Lange
L
L
Truscott
T G
TG
D000975:Antioxidants / Q000378:metabolism*; D001205:Ascorbic Acid / Q000378:metabolism; D002338:Carotenoids / Q000378:metabolism; D002455:Cell Division; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D005347:Fibroblasts / Q000166:cytology; D006801:Humans; D019169:Jurkat Cells; D008027:Light; D000077276:Lycopene; D011524:Protoporphyrins / Q000378:metabolism / Q000633:toxicity*; D014578:Uroporphyrins / Q000378:metabolism / Q000633:toxicity*; D024502:alpha-Tocopherol / Q000378:metabolism; D019207:beta Carotene / Q000378:metabolism
D000975:Antioxidants; D011524:Protoporphyrins; D014578:Uroporphyrins; D019207:beta Carotene; D002338:Carotenoids; C034103:uroporphyrin I; C028025:protoporphyrin IX; D024502:alpha-Tocopherol; D001205:Ascorbic Acid; D000077276:Lycopene